{"id":"https://openalex.org/W7204686140","doi":"https://doi.org/10.1016/s2152-2650(26)01072-4","title":"POSTER: ABCL-142: Golcadomide\u2014A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy","display_name":"POSTER: ABCL-142: Golcadomide\u2014A Potential First-in-Class Oral CELMoD Combined With Pola-R-CHP in Frontline Aggressive B-Cell Lymphoma: Safety and 12-Month Efficacy","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204686140","doi":"https://doi.org/10.1016/s2152-2650(26)01072-4"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)01072-4","doi":"https://doi.org/10.1016/s2152-2650(26)01072-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01072-4","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032001510","display_name":"Muhamad Alhaj Moustafa","orcid":"https://orcid.org/0000-0001-8582-1219","observed_orcids":["https://orcid.org/0000-0001-8582-1219"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhamad Alhaj Moustafa","raw_affiliation_strings":["Mayo Clinic, Jacksonville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Jacksonville, FL, USA","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103140363","display_name":"Theodoros Vassilakopoulos","orcid":"https://orcid.org/0000-0003-0254-8638","observed_orcids":["https://orcid.org/0000-0003-0254-8638"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]},{"id":"https://openalex.org/I4210114623","display_name":"Laiko General Hospital of Athens","ror":"https://ror.org/02dvs1389","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210114623"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Theodoros Vassilakopoulos","raw_affiliation_strings":["National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece","institution_ids":["https://openalex.org/I200777214","https://openalex.org/I4210114623"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Grzegorz Nowakowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grzegorz Nowakowski","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148624000","display_name":"Michal Kwiatek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I120230055","display_name":"Poznan University of Medical Sciences","ror":"https://ror.org/02zbb2597","country_code":"PL","type":"education","lineage":["https://openalex.org/I120230055"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Michal Kwiatek","raw_affiliation_strings":["Poznan University of Medical Sciences, Poznan, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Poznan University of Medical Sciences, Poznan, Poland","institution_ids":["https://openalex.org/I120230055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004034518","display_name":"Maria Bouzani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166445","display_name":"Evangelismos Hospital","ror":"https://ror.org/05q4veh78","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210166445"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Maria Bouzani","raw_affiliation_strings":["Evaggelismos General Hospital, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evaggelismos General Hospital, Athens, Greece","institution_ids":["https://openalex.org/I4210166445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088298351","display_name":"Dagmara Zimowska\u2010Cury\u0142o","orcid":"https://orcid.org/0000-0002-4117-3667","observed_orcids":["https://orcid.org/0000-0002-4117-3667"]},"institutions":[{"id":"https://openalex.org/I4210166853","display_name":"Szpital Uniwersytecki w Krakowie","ror":"https://ror.org/05vgmh969","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210166853"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Dagmara Zimowska-Curylo","raw_affiliation_strings":["Krakow University Hospital, Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Krakow University Hospital, Krakow, Poland","institution_ids":["https://openalex.org/I4210166853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148687658","display_name":"Alejandro Mart\u00edn Garc\u00eda-Sancho","orcid":"https://orcid.org/0000-0001-6330-1028","observed_orcids":["https://orcid.org/0000-0001-6330-1028"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alejandro Mart\u00edn Garc\u00eda-Sancho","raw_affiliation_strings":["Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045","https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083191976","display_name":"Juan\u2010Manuel Sancho","orcid":"https://orcid.org/0000-0001-7168-6538","observed_orcids":["https://orcid.org/0000-0001-7168-6538"]},"institutions":[{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan-Manuel Sancho","raw_affiliation_strings":["Germans Trias i Pujol University Hospital, ICO-IJC-Badalona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Germans Trias i Pujol University Hospital, ICO-IJC-Badalona, Spain","institution_ids":["https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148694245","display_name":"Wojciech Jurczak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wojciech Jurczak","raw_affiliation_strings":["MSC National Research Institute of Oncology, Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MSC National Research Institute of Oncology, Krakow, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069647453","display_name":"Arpankumar Patel","orcid":"https://orcid.org/0000-0001-7416-2211","observed_orcids":["https://orcid.org/0000-0001-7416-2211"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arpankumar Patel","raw_affiliation_strings":["Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061066549","display_name":"Floriane Boucaud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Floriane Boucaud","raw_affiliation_strings":["Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Boudry, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Boudry, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047255931","display_name":"Argyrios Gkasiamis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Argyrios Gkasiamis","raw_affiliation_strings":["Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Boudry, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Boudry, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112043216","display_name":"Mark Kaplan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Kaplan","raw_affiliation_strings":["Translational Development, Bristol Myers Squibb, Madison, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Development, Bristol Myers Squibb, Madison, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004531828","display_name":"Arnaud Amzallag","orcid":"https://orcid.org/0000-0001-7467-1227","observed_orcids":["https://orcid.org/0000-0001-7467-1227"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arnaud Amzallag","raw_affiliation_strings":["Informatics and Predictive Sciences, Bristol Myers Squibb, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Informatics and Predictive Sciences, Bristol Myers Squibb, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001241470","display_name":"Matt Stokes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt Stokes","raw_affiliation_strings":["Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026840897","display_name":"Tanvi Jindia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tanvi Jindia","raw_affiliation_strings":["Global Biometrics and Data Sciences, Bristol Myers Squibb, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Biometrics and Data Sciences, Bristol Myers Squibb, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014819109","display_name":"Serena Kimi Perna","orcid":"https://orcid.org/0000-0002-8892-3955","observed_orcids":["https://orcid.org/0000-0002-8892-3955"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Serena Perna","raw_affiliation_strings":["Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Madison, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Madison, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":null,"display_name":"Marc Hoffmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097601","display_name":"The University of Kansas Cancer Center","ror":"https://ror.org/00cj35179","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210097601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Hoffmann","raw_affiliation_strings":["The University of Kansas Cancer Center, Kansas City, KS, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Kansas Cancer Center, Kansas City, KS, USA","institution_ids":["https://openalex.org/I4210097601"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.68218744,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S301","last_page":"S301"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8784000277519226,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8784000277519226,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.09399999678134918,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.017000000923871994,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celmod","display_name":"CELMoD","score":0.871999979019165},{"id":"https://openalex.org/keywords/aggressive-b-cell-lymphoma","display_name":"aggressive B-cell lymphoma","score":0.8629999756813049},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.49000000953674316},{"id":"https://openalex.org/keywords/first-in-class-drugs","display_name":"first-in-class drugs","score":0.6520000100135803},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.7049999833106995},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9812999963760376},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5034999847412109},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.33390000462532043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3237000107765198},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.31119999289512634},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2606000006198883},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.25429999828338623},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.24130000174045563},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.20469999313354492},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.20069999992847443}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)01072-4","doi":"https://doi.org/10.1016/s2152-2650(26)01072-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01072-4","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-08-31T00:00:00"}